These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

800 related items for PubMed ID: 19151372

  • 1. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
    Boissonneault V, Filali M, Lessard M, Relton J, Wong G, Rivest S.
    Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
    [Abstract] [Full Text] [Related]

  • 2. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
    Olcese JM, Cao C, Mori T, Mamcarz MB, Maxwell A, Runfeldt MJ, Wang L, Zhang C, Lin X, Zhang G, Arendash GW.
    J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338
    [Abstract] [Full Text] [Related]

  • 3. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F, Liu S, Battaglia F, Walter S, Mathews PM, Arancio O.
    Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
    [Abstract] [Full Text] [Related]

  • 4. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T, Kiliaan AJ, Kadish I.
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [Abstract] [Full Text] [Related]

  • 5. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.
    Leon WC, Canneva F, Partridge V, Allard S, Ferretti MT, DeWilde A, Vercauteren F, Atifeh R, Ducatenzeiler A, Klein W, Szyf M, Alhonen L, Cuello AC.
    J Alzheimers Dis; 2010 Sep; 20(1):113-26. PubMed ID: 20164597
    [Abstract] [Full Text] [Related]

  • 6. Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice.
    Pan X, Gong N, Zhao J, Yu Z, Gu F, Chen J, Sun X, Zhao L, Yu M, Xu Z, Dong W, Qin Y, Fei G, Zhong C, Xu TL.
    Brain; 2010 May; 133(Pt 5):1342-51. PubMed ID: 20385653
    [Abstract] [Full Text] [Related]

  • 7. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
    He J, Luo H, Yan B, Yu Y, Wang H, Wei Z, Zhang Y, Xu H, Tempier A, Li X, Li XM.
    Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
    [Abstract] [Full Text] [Related]

  • 8. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Sipos E, Kurunczi A, Kasza A, Horváth J, Felszeghy K, Laroche S, Toldi J, Párducz A, Penke B, Penke Z.
    Neuroscience; 2007 Jun 15; 147(1):28-36. PubMed ID: 17499931
    [Abstract] [Full Text] [Related]

  • 9. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.
    Lue LF, Walker DG, Brachova L, Beach TG, Rogers J, Schmidt AM, Stern DM, Yan SD.
    Exp Neurol; 2001 Sep 15; 171(1):29-45. PubMed ID: 11520119
    [Abstract] [Full Text] [Related]

  • 10. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N, Mamcarz M, Zhu Y, Buzzeo R, Tan J, Arendash GW, Bradshaw PC.
    J Alzheimers Dis; 2010 Sep 15; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [Abstract] [Full Text] [Related]

  • 11. Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease.
    Feng Z, Chang Y, Cheng Y, Zhang BL, Qu ZW, Qin C, Zhang JT.
    J Pineal Res; 2004 Sep 15; 37(2):129-36. PubMed ID: 15298672
    [Abstract] [Full Text] [Related]

  • 12. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.
    Malm TM, Koistinaho M, Pärepalo M, Vatanen T, Ooka A, Karlsson S, Koistinaho J.
    Neurobiol Dis; 2005 Feb 15; 18(1):134-42. PubMed ID: 15649704
    [Abstract] [Full Text] [Related]

  • 13. An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease.
    Lord A, Gumucio A, Englund H, Sehlin D, Sundquist VS, Söderberg L, Möller C, Gellerfors P, Lannfelt L, Pettersson FE, Nilsson LN.
    Neurobiol Dis; 2009 Dec 15; 36(3):425-34. PubMed ID: 19703562
    [Abstract] [Full Text] [Related]

  • 14. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
    Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, Cracchiolo JR, Shippy D, Tan J.
    Neuroscience; 2006 Nov 03; 142(4):941-52. PubMed ID: 16938404
    [Abstract] [Full Text] [Related]

  • 15. Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice.
    Arendash GW, Mori T, Cao C, Mamcarz M, Runfeldt M, Dickson A, Rezai-Zadeh K, Tane J, Citron BA, Lin X, Echeverria V, Potter H.
    J Alzheimers Dis; 2009 Nov 03; 17(3):661-80. PubMed ID: 19581722
    [Abstract] [Full Text] [Related]

  • 16. The effects of long-term treatment with metrifonate, a cholinesterase inhibitor, on cholinergic activity, amyloid pathology, and cognitive function in APP and PS1 doubly transgenic mice.
    Liu L, Ikonen S, Heikkinen T, Tapiola T, van Groen T, Tanila H.
    Exp Neurol; 2002 Feb 03; 173(2):196-204. PubMed ID: 11822883
    [Abstract] [Full Text] [Related]

  • 17. Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes.
    Howlett DR, Richardson JC, Austin A, Parsons AA, Bate ST, Davies DC, Gonzalez MI.
    Brain Res; 2004 Aug 13; 1017(1-2):130-6. PubMed ID: 15261108
    [Abstract] [Full Text] [Related]

  • 18. Lifelong immunization with human beta-amyloid (1-42) protects Alzheimer's transgenic mice against cognitive impairment throughout aging.
    Jensen MT, Mottin MD, Cracchiolo JR, Leighty RE, Arendash GW.
    Neuroscience; 2005 Aug 13; 130(3):667-84. PubMed ID: 15590151
    [Abstract] [Full Text] [Related]

  • 19. [The lesions of Alzheimer's disease: which therapeutic perspectives?].
    Duyckaerts C, Perruchini C, Lebouvier T, Potier MC.
    Bull Acad Natl Med; 2008 Feb 13; 192(2):303-18; discussion 318-21. PubMed ID: 18819685
    [Abstract] [Full Text] [Related]

  • 20. Increased Abeta production leads to intracellular accumulation of Abeta in flotillin-1-positive endosomes.
    Rajendran L, Knobloch M, Geiger KD, Dienel S, Nitsch R, Simons K, Konietzko U.
    Neurodegener Dis; 2007 Feb 13; 4(2-3):164-70. PubMed ID: 17596711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.